Complete response to weekly carboplatin–docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer

Abstract Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of otolaryngology Vol. 36; no. 2; pp. 268 - 272
Main Authors Koussis, Haralabos, MD, Giorgi, Carlo Alberto, MD, Di Liso, Elisabetta, MD, Carlucci, Maria Concetta, Psy, Fassina, Ambrogio, MD, Marioni, Gino, MD, Conte, Pier Franco, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2015
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive tumor. Herein, we reported a case of a 91-year-old woman with complete response after induction chemotherapy (weekly carboplatin and docetaxel) that underwent subsequent radiotherapy.
Bibliography:ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
ISSN:0196-0709
1532-818X
DOI:10.1016/j.amjoto.2014.03.006